MyBlueDotsPureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) MyBlueDots5 months ago01 mins BOSTON–(BUSINESS WIRE)–PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) Post navigation Previous: Henry Schein Opens Customer Emergency Support Hotline in Response to California FiresNext: What Illinois residents should know, following the first US death from bird virus
Minutes instead of months: Algorithm rapidly identifies cell types to match patients with effective cancer therapies MyBlueDots2 days ago 0
Potential Medicaid cuts could lead to more than 16,500 medically-preventable deaths each year MyBlueDots2 days ago 0
Integrative exome sequencing and machine learning identify new genes contributing to systemic sclerosis risk MyBlueDots2 days ago 0